NLRP3/inflammasome activation contributes to aldosterone-induced vascular dysfunction in type 2 diabetes (2016)
- Authors:
- USP affiliated authors: ALVES FILHO, JOSÉ CARLOS FARIAS - FMRP ; PASSAGLIA, RITA DE CASSIA ALEIXO TOSTES - FMRP
- Unidade: FMRP
- Subjects: INFLAMAÇÃO; ALDOSTERONA; DIABETES MELLITUS
- Language: Inglês
- Imprenta:
- Source:
- Título: Final Program
- Conference titles: Council on Hypertension 2016
-
ABNT
FERREIRA, Nathanne S. et al. NLRP3/inflammasome activation contributes to aldosterone-induced vascular dysfunction in type 2 diabetes. 2016, Anais.. Orlando: AHA, 2016. . Acesso em: 01 abr. 2026. -
APA
Ferreira, N. S., Bruder-Nascimento, T., Pereira, C. A., Zanotto, C. Z., Prado, D. S., Alves-Filho, J. C., et al. (2016). NLRP3/inflammasome activation contributes to aldosterone-induced vascular dysfunction in type 2 diabetes. In Final Program. Orlando: AHA. -
NLM
Ferreira NS, Bruder-Nascimento T, Pereira CA, Zanotto CZ, Prado DS, Alves-Filho JC, Carlos D, Tostes R de CA. NLRP3/inflammasome activation contributes to aldosterone-induced vascular dysfunction in type 2 diabetes. Final Program. 2016 ;[citado 2026 abr. 01 ] -
Vancouver
Ferreira NS, Bruder-Nascimento T, Pereira CA, Zanotto CZ, Prado DS, Alves-Filho JC, Carlos D, Tostes R de CA. NLRP3/inflammasome activation contributes to aldosterone-induced vascular dysfunction in type 2 diabetes. Final Program. 2016 ;[citado 2026 abr. 01 ] - Therapeutic effects of treatment with anti-TLR2 and anti-TLR4 monoclonal antibodies in polymicrobial sepsis
- Nitric oxide-induced regulatory T cells inhibit Th 17 but not Th1 cell differentiation and function
- Pyruvate kinase M2: a potential target for regulating inflammation
- Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis
- IL-33 induces skin inflammation with mast cell and neutrophil activation
- ILC2s and basophils team up to orchestrate IL-33–induced atopic dermatitis [Comentário]
- O papel do receptor GPR91 na polarização de macrófagos
- SOCS1 is a negative regulator of metabolic reprogramming during sepsis
- IL-33 attenuates EAE by suppressing IL-17 and IFN-y production and inducing alternatively activated macrophages
- IL-33 attenuates the development of experimental autoimmune uveitis
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
